Macrovascular Risk Equations Based on the CANVAS Program.
Michael WillisChristian AsseburgApril SleeAndreas NilssonCheryl NeslusanPublished in: PharmacoEconomics (2021)
These risk equations address some of the limitations of widely used risk equations, such as the UKPDS-OM2, for modeling cardioprotective treatments for individuals with T2DM and high cardiovascular risk, including derivation from overly healthy patients treated with agents that lack cardioprotection and have been described as reflecting a different therapeutic era. Future work is needed to examine external validity.